Literature DB >> 10644927

Age-sensitive cognitive function, growth hormone and insulin-like growth factor 1 plasma levels in healthy older men.

A Aleman1, W R de Vries, E H de Haan, H J Verhaar, M M Samson, H P Koppeschaar.   

Abstract

Circulating levels of growth hormone (GH) change during the process of aging. Decline of cognitive functioning with aging is also well established. In this study, we investigated whether insulin-like growth factor 1 (IGF-1) and the GH response to a challenge of GH-releasing hormone and GH-releasing peptide 6 were associated with age-sensitive cognitive functions, but not with functions that do not decline with aging, in 17 healthy male subjects aged between 66 and 76 years. In addition, relations with anthropometric measures were examined. Neuropsychological performance was scored on tests of variables not sensitive to aging (general knowledge, vocabulary, basic visual perception and reading ability), and of variables sensitive to aging (visuoconstructive ability, perceptual motor and mental processing speed, and verbal long-term memory). After correcting for education, the serum GH response was significantly associated with two age-sensitive cognitive tests (measures of mental processing speed), but with none of the tests not sensitive to aging. However, the direction of the association was opposite to the relation between IGF-1 and these cognitive tests: higher levels of GH response were associated with poorer cognitive performance, whereas higher levels of IGF-1 were associated with better performance. GH response, but not IGF-1, was inversely correlated with body mass index. The results are in accordance with previous research suggesting a disruption of the relation between IGF-1 and GH secretion in older age. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644927     DOI: 10.1159/000026636

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  12 in total

Review 1.  Programs of gene expression during the laying down of memory formation as revealed by DNA microarrays.

Authors:  Sebastiano Cavallaro; Velia Dagata; Daniel L Alkon
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

2.  Cognitive function in acromegaly: description and brain volumetric correlates.

Authors:  Caroline Sievers; P G Sämann; H Pfister; C Dimopoulou; M Czisch; J Roemmler; J Schopohl; G K Stalla; J Zihl
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

3.  Growth hormone induces age-dependent alteration in the expression of hippocampal growth hormone receptor and N-methyl-D-aspartate receptor subunits gene transcripts in male rats.

Authors:  Madeleine Le Grevès; Pia Steensland; Pierre Le Grevès; Fred Nyberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

Review 4.  Growth hormone/insulin-like growth factor I axis in neurodegenerative diseases.

Authors:  M Gasperi; A E Castellano
Journal:  J Endocrinol Invest       Date:  2010-09       Impact factor: 4.256

5.  Neuropsychological recovery and quality-of-life in children and adolescents with growth hormone deficiency following TBI: a preliminary study.

Authors:  Julia B Wamstad; Kenneth W Norwood; Alan D Rogol; Matthew J Gurka; Mark D Deboer; James A Blackman; Marcia L Buck; Michelle N Kuperminc; Jodi G Darring; Peter D Patrick
Journal:  Brain Inj       Date:  2013       Impact factor: 2.311

6.  Insulinlike growth factor-1, insulinlike growth factor binding protein-1, and cognitive function in older men and women.

Authors:  Wael K Al-Delaimy; Denise von Muhlen; Elizabeth Barrett-Connor
Journal:  J Am Geriatr Soc       Date:  2009-06-08       Impact factor: 5.562

7.  Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimates.

Authors:  Eric R Braverman; Thomas J H Chen; Thomas J Prihoda; William Sonntag; Brian Meshkin; B William Downs; Julie F Mengucci; Seth H Blum; Alison Notaro; Vanessa Arcuri; Michael Varshavskiy; Kenneth Blum
Journal:  Age (Dordr)       Date:  2007-05-12

8.  Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial.

Authors:  Laura D Baker; Suzanne M Barsness; Soo Borson; George R Merriam; Seth D Friedman; Suzanne Craft; Michael V Vitiello
Journal:  Arch Neurol       Date:  2012-11

9.  Growth Hormone-Releasing Hormone Modulation of Neuronal Exosome Biomarkers in Mild Cognitive Impairment.

Authors:  Charisse N Winston; Edward J Goetzl; Laura D Baker; Michael V Vitiello; Robert A Rissman
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

10.  Insulin-like growth factor I and the pathogenesis of delirium: a review of current evidence.

Authors:  Dimitrios Adamis; David Meagher
Journal:  J Aging Res       Date:  2011-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.